Immune-mediated attenuation of HIV-1

Author： Chopera Denis R   Wright Jaclyn K   Brockman Mark A   Brumme Zabrina L  

Publisher： Future Medicine

ISSN： 1746-0794

Source： Future Virology, Vol.6, Iss.8, 2011-08, pp. : 917-928

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Piperacillin: Immune-mediated haemolytic crisis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1315, 2010-01 ,pp. : 40-40

Adis International

Access to resources Recommend Favorite

Efficacy and safety of etanercept in chronic immune-mediated disease

By Murdaca Giuseppe   Spanò Francesca   Contatore Miriam   Guastalla Andrea   Magnani Ottavia   Puppo Francesco  

Expert Opinion on Drug Safety, Vol. 13, Iss. 5, 2014-05 ,pp. : 649-661

Informa Healthcare

Access to resources Recommend Favorite

Oxaliplatin: Immune-mediated thrombocytopenia: case report

By  

Reactions Weekly, Vol. 1, Iss. 1308, 2010-01 ,pp. : 27-28

Adis International

Access to resources Recommend Favorite

ITK Inhibitors in Inflammation and Immune-Mediated Disorders

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 8, 2009-05 ,pp. : 690-703

Bentham Science Publishers

Access to resources Recommend Favorite

Biologics in Inflammatory Immune-mediated Systemic Diseases

By  

Current Pharmaceutical Biotechnology, Vol. 18, Iss. 12, 2018-03 ,pp. : 1008-1016

Bentham Science Publishers

Access to resources Recommend Favorite